Stocks
HCW Biologics Inc.HCWB
NASDAQHealthcareBiotechnology$1.17
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer and inflammatory diseases. Its lead product candidates are based on a proprietary platform that targets the IL-2 and IL-15 signaling pathways. Investors track the company for its potential in the immuno-oncology space, though it has yet to generate revenue.
52W Range: $1.09-$23.94
Congressional Interest in HCW Biologics Inc. (HCWB)
No congressional trades have been disclosed for HCW Biologics Inc. (HCWB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HCWB?
No congressional trades found for this stock.